Sartorius Aktiengesellschaft (VIE:SATG)
Austria flag Austria · Delayed Price · Currency is EUR
192.00
+1.00 (0.52%)
At close: Feb 27, 2026

Sartorius Aktiengesellschaft Company Description

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide.

The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products.

It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions.

The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries.

The company was founded in 1870 and is headquartered in Göttingen, Germany.

Sartorius Aktiengesellschaft
Country Germany
Founded 1870
Industry Laboratory Analytical Instruments
Employees 13,671
CEO Michael Grosse

Contact Details

Address:
Otto-Brenner-Strasse 20
Göttingen, 37079
Germany
Phone 49 551 308 0
Website sartorius.com

Stock Details

Ticker Symbol SATG
Exchange Vienna Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 3826

Key Executives

Name Position
Michael Grosse Chief Executive Officer
Florian Funck Chief Financial Officer